LABU Trend reversal Viés de alta

Direxion Daily S&P Biotech Bull 3X SharesArca

Descrição

⋅ 25 de Abr de 2019 05:23

got out of LABD to buy LABU on next pullback down to about $88.40 earnings growth and M&A optimism to reestablish in biotech/ healthcare. watching that ceiling of resistance to potentially pull profits

Mais